On November 18, 2024, Samsung Bioepis announced that the European Commission (EC) has approved its aflibercept biosimilar, OPUVIZ.

On 17 October, the European Commission (EC) issued its Fourth Annual Report under Article 5(4) of the Foreign Direct Investments (FDI) ...

The Jülich Supercomputing Centre (JSC) at Forschungszentrum Jülich in Germany received a 100-qubit quantum computer from ...

Days of tension have culminated in a high-stakes vote in parliament that could trigger a financial crisis for the eurozone’s ...

The EU states will set up a cyber security warning system with which they want to be able to recognize and ward off threats ...

Parliament’s Natural Resources committee voted unanimously Monday to call on Paper Excellence owner Jackson Wijaya to testify ...

JD Sports Fashion Plc has completed its acquisition of Groupe Courir S.A.S. following receipt of conditional clearance from ...

Countries negotiating the treaty have agreed to meet again in 2025, with issues of production caps, program funding and ...

The launch underscores European companies’ and individuals’ commitment to creating a dynamic platform for enhancing trade relations and fostering mutual growth, EuroCham officials say ...

After a rough few months for Intercept and Advanz Pharma's Ocaliva on both sides of the Atlantic, the other shoe has dropped for the rare liver disease drug in Europe. | The General Court of the ...

The term Digital Twin of the Earth creates the idea of the availability of a highly accurate virtual copy of our planet, ...

In an exclusive interview with the Kyiv Independent, Kaja Kallas, the newly appointed vice-president of the European ...